What is Mannkind's other commercial liabilities?

Mannkind (MNKD) reported other commercial liabilities of $58.6M in Q1 2026.

How has Mannkind's other commercial liabilities changed year-over-year?

Mannkind's other commercial liabilities increased by 46.1% year-over-year, from $40.1M to $58.6M.

What is the long-term trend for Mannkind's other commercial liabilities?

Over 5 years (2020 to 2025), Mannkind's other commercial liabilities has grown at a 26.8% compound annual growth rate (CAGR), from $19.71M to $64.63M.

Mannkind MNKD Other Commercial Liabilities

Other Commercial Liabilities at other companies

Lexicon PharmaceuticalsLXRX

——

Opko HealthOPK

——

Mineralys Therapeutics, Inc.MLYS

——

Eton Pharmaceuticals, Inc.ETON

——

Omada Health, Inc. Common StockOMDA

——

Kiniksa Pharmaceuticals International, plcKNSA

——

Other financials

Income statement

See full

Revenue$90.2M+15.1%

Gross profit$82.7M+10.8%

Operating income-$1.7M-107%

Net income-$16.6M-226%

EPS (diluted)-$0.05-225%

Balance sheet

See full

Cash & equivalents$52.8M+11.7%

Total debt$12.2M-9.4%

Total equity-$59.2M-1.0%

Total assets$744.4M+81.5%

Cash flow

See full

Operating cash flow-$5.4M+15.9%

CapEx$1.9M+470%

Free cash flow-$7.2M-8.0%

Valuation

See full

Market cap$1.19B-50.6%

Enterprise value$1.15B-52.2%

P/E228.5×—

P/S3.3×-4.8×

Profitability

See full

Gross margin91.5%-2.6pp

Operating margin23.3%+3.1pp

Net margin9.3%—

FCF margin13.8%—

Returns & leverage

See full

Return on equity-8.8%—

Debt / equity-0.2×—

Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mannkind's other commercial liabilities?: Mannkind (MNKD) reported other commercial liabilities of $58.6M in Q1 2026.
How has Mannkind's other commercial liabilities changed year-over-year?: Mannkind's other commercial liabilities increased by 46.1% year-over-year, from $40.1M to $58.6M.
What is the long-term trend for Mannkind's other commercial liabilities?: Over 5 years (2020 to 2025), Mannkind's other commercial liabilities has grown at a 26.8% compound annual growth rate (CAGR), from $19.71M to $64.63M.